From a pharmacological perspective, quercetin nanoparticles have demonstrated beneficial effects against Alzheimer’s disease, primarily through their inhibitory impact on acetylcholinesterase. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.